Value Research

Nahar Spinning Mills Limited manufactures and sells yarns and knitted garments primarily in India. The company offers raw white combed, raw white carded/open end, dyed, organic cotton, fair trade cotton, better cotton initiative, melange, gassed/mercerized, compact spun, blended, synthetic/man-made fiber, and cleaner yarns, as well as grindle, space dyed, slub, core spun, high twist, reverse twist, and elitwist yarns. It also provides woolen/cotton hosiery knit-wears and woolen textiles; and T-shirts. The company also exports its products primarily to the United States, the United Kingdom, France, Brazil, Bangladesh, Mauritius, Honduras, Argentina, Colombia, Peru, Chile, the Netherlands, Japan, Canada, Korea, Taiwan, Hong Kong, Singapore, Egypt, and Russia. Nahar Spinning Mills Limited was incorporated in 1980 and is based in Ludhiana, India. It has an equity base of just Rs.18.03crore that is supported by reserves of around Rs.742.27crore. It has a share book value of Rs.211. Th

Balaji Telefilms (BTL) was incorporated as a private limited company and subsequently converted to a public limited company in Feb., 2000. The company is promoted by Ravi Kapoor, Shobha Kapoor and Ekta Kapoor. Headquartered in Mumbai, the promoter family owns 42 per cent of the company`s equity.  Balaji is currently providing content to most of the Hindi satellite channels, Gemini in Telugu and Udaya in Kannada. Its success in the television software market is attributed to its early entry into the market and its local presence at Mumbai, Chennai & Bangalore.  As of March 2006, Balaji Telefilms runs seven soaps on Star Plus, one show on Zee TV and two shows on Sony. The production house also has seven shows for the southern market. Nearly 85 percent of its revenue comes from Hindi programming, 8 percent from Telugu, 5 percent from Kannada and 4 percent from Tamil and Malayalam. BTL content caters to a wide spectrum of audience through its diverse software which includes sitcoms, s

Dengue and Malaria are becoming uncontrollable. Mangalam Drugs Organics should post handsome growth especially with the backing of the Bill Clinton Foundation. The share has nearly doubled after Our recommended it a few months back   Dishman Pharmaceuticals has been licensed by Johnson & Johnson, USA, to manufacture a TB drug raw material. Very positive news for its share price.